tiprankstipranks

Pol Boudes Insider Profile

4 Followers
Pol Boudes, Director at Protalix, holds 7.54K shares in Protalix (Ticker: PLX), holds ― shares in Galectin Therapeutics (Ticker: GALT), holds 0.00 shares in CymaBay Therapeutics (Ticker: CBAY).
tipranks
Pol Boudes

Pol Boudes
Protalix (PLX)
Director

Not Ranked
Pol Boudes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$20K
100.00%
0.00%
A breakdown of Pol Boudes's holdings

Insider Roles

Protalix
(PLX)
Director
Galectin Therapeutics
(GALT)
CMO
Roles that Pol Boudes holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Pol Boudes

Pol Boudes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Protalix
Sep 04, 2025
Director
Uninformative Buy
$20.13K
Galectin Therapeutics
CMO
CBAY
CymaBay Therapeutics
$0.00
FOLD
Amicus
$0.00
List of latest transactions for each holding click on a transaction to see Pol Boudes's performance on stock

Pol Boudes insider profile FAQ

What is the percentage of profitable transactions made by Pol Boudes?
The percentage of profitable transactions made by Pol Boudes is ―.
    What is the average return per transaction made by Pol Boudes?
    The average return per transaction made by Pol Boudes is ―.
      What stocks does Pol Boudes hold?
      Pol Boudes holds: PLX, GALT, CBAY, FOLD stocks.
        What was Pol Boudes’s latest transaction?
        Pol Boudes latest transaction was an Uninformative Buy of ―.
          What was Pol Boudes's most profitable transaction?
          Pol Boudes’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Pol Boudes's role in Protalix?
            Pol Boudes's role in Protalix is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.